Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...

The study also explored the impact of PDK1 Y163 phosphorylation on lung cancer cell proliferation, invasion, and metabolism.

A liquid biopsy looks for DNA mutations such as EGFR, ALK, and KRAS in cancer cells circulating in your blood. Certain treatments target those mutations. Another tool in lung cancer diagnosis ...

Jan. 6, 2025 — Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer ... Scientists Develop Scans That Light-Up Aggressive ...

In December 2024, the FDA approved Ensacove as a first-line treatment for non-small-cell lung cancer (NSCLC) in certain adults. NSCLC is the most common type of lung cancer. Ensacove may also ...

Precious metals are not merely ornaments; they are also important components of pharmaceuticals, like the antitumor drug ...

Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

The team developed experimental models of lung cancer in the lab, then used artificial intelligence to analyze them, identifying noncancerous cells and how they organized within and around the ...